Comprehensive Assessment of Reactogenicity and Safety of the Live-Attenuated Chikungunya Vaccine (IXCHIQ<sup>®</sup>)
<b>Background/Objectives:</b> This overview provides a comprehensive safety evaluation of the approved live-attenuated vaccine VLA1553 (IXCHIQ<sup>®</sup>) for active immunization for the prevention of disease caused by chikungunya virus (CHIKV) in clinical trials. <b>M...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-05-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/13/6/576 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|